Related Articles
An osteopontin promoter polymorphism is associated with aggressiveness in breast cancer
Silencing of <em>GRHL2</em> induces epithelial‑to‑mesenchymal transition in lung cancer cell lines with different effects on proliferation and clonogenic growth
Features of ovarian cancer in Lynch syndrome (Review)
Plasma osteopontin concentrations in patients with cutaneous melanoma
Deficient mismatch repair: Read all about it (Review)